Join 100+ industry leaders at the 5th Gene Therapy for Ophthalmic Disorders Summit to uncover cutting-edge gene therapy breakthroughs. Harness the latest developments in vector engineering to target retinal cells more effectively with higher transduction efficiency.

This webinar will explore the utility of a Universal AAV Standard in assessing the quantity and genomic integrity of AAV vectors.